PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) said its second-quarter GAAP net income attributable to the company grew to $863 million or $0.99 per share, from $576 million or $0.64 per share a year ago, with non-GAAP net income rising to $1.12 billion or $1.28 per share, from $0.98 billion or $1.10 per share in the second quarter of 2011. On average, 22 analysts polled by Thomson Reuters expected earnings per share of $1.28 for the quarter. Analysts' estimates typically exclude one-time items.
Net revenues of $5.0 billion, increased by 19% over last year's $4.2 billion. Analysts estimated revenues of $5.08 billion for the quarter.
In addition, the company has reaffirmed its full-year 2012 guidance; while at its meeting on July 31, 2012, the board declared a cash dividend for the second quarter of NIS 1.00 per share.
Copyright RTT News/dpa-AFX
Kostenloser Wertpapierhandel auf Smartbroker.de